NEW YORK CITY, NY / ACCESS Newswire / March 4, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

H.C. Wainwright analyst Ed Arce raised the firm’s price target on Akero Therapeutics (AKRO) to $75 from $72 and keeps a Buy rating on the ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Agilon Health (AGL) is a stock that can certainly grab the ...

Insider Activity In other news, COO Jonathan Young sold 2,503 shares of Akero Therapeutics stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $30.79 ...

AKRO opened at $54.08 on Friday. Akero Therapeutics has a 12-month low of $15.32 and a 12-month high of $58.40. The company has a current ratio of 17.25, a quick ratio of 17.25 and a debt-to ...

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best booming stocks to invest in now. The U.S. stock market closed on a downbeat ...

Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio? Check out this week's top-performing mid-cap stocks ...

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best performing pharma stocks so far in 2025. On February 20, Jared Holz ...

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against the other biotech stocks. No matter the market environment, you’ll always find ...